| Reduced glial cell density and neuronal size in the anterior cingulate cortex in major depressive disorder D Cotter, D Mackay, S Landau, R Kerwin, I Everall Archives of general psychiatry 58 (6), 545-553, 2001 | 969 | 2001 |
| Reduced neuronal size and glial cell density in area 9 of the dorsolateral prefrontal cortex in subjects with major depressive disorder D Cotter, D Mackay, G Chana, C Beasley, S Landau, IP Everall Cerebral cortex 12 (4), 386-394, 2002 | 788 | 2002 |
| Glial cell abnormalities in major psychiatric disorders: the evidence and implications DR Cotter, CM Pariante, IP Everall Brain research bulletin 55 (5), 585-595, 2001 | 579 | 2001 |
| The prevalence of psychosis in epilepsy; a systematic review and meta-analysis MJ Clancy, MC Clarke, DJ Connor, M Cannon, DR Cotter BMC psychiatry 14, 1-9, 2014 | 381 | 2014 |
| Proteomic analysis of the anterior cingulate cortex in the major psychiatric disorders: evidence for disease‐associated changes CL Beasley, K Pennington, A Behan, R Wait, MJ Dunn, D Cotter Proteomics 6 (11), 3414-3425, 2006 | 335 | 2006 |
| Two-dimensional assessment of cytoarchitecture in the anterior cingulate cortex in major depressive disorder, bipolar disorder, and schizophrenia: evidence for decreased … G Chana, S Landau, C Beasley, IP Everall, D Cotter Biological psychiatry 53 (12), 1086-1098, 2003 | 297 | 2003 |
| Youth mental health in the time of COVID-19 E Power, S Hughes, D Cotter, M Cannon Irish journal of psychological medicine 37 (4), 301-305, 2020 | 264 | 2020 |
| Prominent synaptic and metabolic abnormalities revealed by proteomic analysis of the dorsolateral prefrontal cortex in schizophrenia and bipolar disorder K Pennington, CL Beasley, P Dicker, A Fagan, J English, CM Pariante, ... Molecular psychiatry 13 (12), 1102-1117, 2008 | 259 | 2008 |
| The density and spatial distribution of GABAergic neurons, labelled using calcium binding proteins, in the anterior cingulate cortex in major depressive disorder, bipolar … D Cotter, S Landau, C Beasley, R Stevenson, G Chana, L MacMillan, ... Biological psychiatry 51 (5), 377-386, 2002 | 249 | 2002 |
| Anti-N-methyl-d-aspartate receptor encephalitis: review of clinical presentation, diagnosis and treatment H Barry, S Byrne, E Barrett, KC Murphy, DR Cotter BJPsych Bulletin 39 (1), 19-23, 2015 | 236 | 2015 |
| Hippocampal FGF-2 and FGFR1 mRNA expression in major depression, schizophrenia and bipolar disorder F Gaughran, J Payne, PM Sedgwick, D Cotter, M Berry Brain research bulletin 70 (3), 221-227, 2006 | 222 | 2006 |
| Proteomic analysis of membrane microdomain-associated proteins in the dorsolateral prefrontal cortex in schizophrenia and bipolar disorder reveals alterations in LAMP, STXBP1 … AT Behan, C Byrne, MJ Dunn, G Cagney, DR Cotter Molecular psychiatry 14 (6), 601-613, 2009 | 217 | 2009 |
| Abnormalities of Wnt signalling in schizophrenia–evidence for neurodevelopmental abnormality D Cotter, R Kerwin, S Al-Sarraji, JP Brion, A Chadwich, S Lovestone, ... Neuroreport 9 (7), 1379-1383, 1998 | 209 | 1998 |
| Cortical selective vulnerability in motor neuron disease: a morphometric study S Maekawa, S Al‐Sarraj, M Kibble, S Landau, J Parnavelas, D Cotter, ... Brain 127 (6), 1237-1251, 2004 | 194 | 2004 |
| Proteomic and genomic evidence implicates the postsynaptic density in schizophrenia M Föcking, LM Lopez, JA English, P Dicker, A Wolff, E Brindley, K Wynne, ... Molecular psychiatry 20 (4), 424-432, 2015 | 173 | 2015 |
| A systematic review of metabolite biomarkers of schizophrenia J Davison, A O'Gorman, L Brennan, DR Cotter Schizophrenia research 195, 32-50, 2018 | 172 | 2018 |
| 2‐D DIGE analysis implicates cytoskeletal abnormalities in psychiatric disease JA English, P Dicker, M Föcking, MJ Dunn, DR Cotter Proteomics 9 (12), 3368-3382, 2009 | 170 | 2009 |
| Inflammation and brain structure in schizophrenia and other neuropsychiatric disorders: a Mendelian randomization study JA Williams, S Burgess, J Suckling, PA Lalousis, F Batool, SL Griffiths, ... JAMA psychiatry 79 (5), 498-507, 2022 | 169 | 2022 |
| Is traumatic brain injury a risk factor for schizophrenia? A meta-analysis of case-controlled population-based studies C Molloy, RM Conroy, DR Cotter, M Cannon Schizophrenia bulletin 37 (6), 1104-1110, 2011 | 169 | 2011 |
| The neuroproteomics of schizophrenia JA English, K Pennington, MJ Dunn, DR Cotter Biological psychiatry 69 (2), 163-172, 2011 | 161 | 2011 |
